SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of ARS Pharmaceuticals, Inc. of an Investigation and Potential Class ...
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of ARS Pharmaceuticals, Inc.: On September 19, 2023, ARS announced it received from the Food and Drug Administration (FDA) a Complete Response Letter …